🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 1 hora
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/10/2007 | 33,65 | 33,75 | 33,20 | 33,45 | -0,59% | 1,63% | 847.000 |
| 08/10/2007 | 33,73 | 33,73 | 33,33 | 33,65 | -0,24% | 1,20% | 554.400 |
| 05/10/2007 | 33,47 | 33,82 | 33,08 | 33,73 | +1,23% | 2,20% | 929.800 |
| 04/10/2007 | 32,83 | 33,53 | 32,74 | 33,32 | +1,69% | 2,39% | 766.200 |
| 03/10/2007 | 32,98 | 33,15 | 32,75 | 32,77 | -0,92% | 1,21% | 1.010.800 |
| 02/10/2007 | 33,41 | 33,46 | 32,87 | 33,07 | -1,28% | 1,78% | 977.400 |
| 01/10/2007 | 33,28 | 33,73 | 32,89 | 33,50 | +0,69% | 2,52% | 1.120.200 |
| 28/09/2007 | 33,26 | 33,73 | 32,88 | 33,27 | -0,25% | 2,56% | 1.028.000 |
| 27/09/2007 | 32,92 | 33,76 | 32,92 | 33,36 | +1,83% | 2,55% | 996.800 |
| 26/09/2007 | 33,10 | 33,19 | 32,67 | 32,76 | -0,56% | 1,59% | 1.019.000 |
| 25/09/2007 | 32,88 | 33,24 | 32,85 | 32,94 | -0,03% | 1,19% | 632.400 |
| 24/09/2007 | 33,50 | 33,59 | 32,92 | 32,95 | -1,66% | 1,99% | 788.000 |
| 21/09/2007 | 33,53 | 33,70 | 33,20 | 33,51 | -0,36% | 1,49% | 1.539.800 |
| 20/09/2007 | 32,95 | 33,68 | 32,94 | 33,63 | +1,51% | 2,25% | 1.351.000 |
| 19/09/2007 | 33,49 | 33,54 | 32,86 | 33,13 | -1,10% | 2,02% | 790.800 |
| 18/09/2007 | 33,34 | 33,62 | 33,00 | 33,50 | +0,62% | 1,86% | 968.800 |
| 17/09/2007 | 33,40 | 33,56 | 33,13 | 33,29 | -0,31% | 1,29% | 614.400 |
| 14/09/2007 | 33,35 | 33,58 | 33,22 | 33,40 | -0,01% | 1,06% | 680.600 |
| 13/09/2007 | 34,30 | 34,30 | 33,38 | 33,40 | -2,38% | 2,67% | 838.200 |
| 12/09/2007 | 34,07 | 34,28 | 33,88 | 34,22 | -0,09% | 1,17% | 1.177.800 |
| 11/09/2007 | 34,37 | 34,63 | 33,96 | 34,25 | +0,38% | 1,96% | 685.000 |
| 10/09/2007 | 34,45 | 34,50 | 33,79 | 34,12 | -0,15% | 2,05% | 888.400 |
| 07/09/2007 | 34,46 | 34,62 | 34,10 | 34,17 | -1,81% | 1,51% | 1.195.600 |
| 06/09/2007 | 34,96 | 35,05 | 34,43 | 34,80 | -0,64% | 1,79% | 764.400 |
| 05/09/2007 | 34,86 | 35,17 | 34,50 | 35,02 | +0,23% | 1,92% | 1.031.400 |
| 04/09/2007 | 34,08 | 35,13 | 34,05 | 34,94 | +2,03% | 3,15% | 656.200 |
| 31/08/2007 | 34,48 | 34,66 | 33,76 | 34,25 | +0,04% | 2,61% | 865.600 |
| 30/08/2007 | 34,06 | 34,60 | 33,82 | 34,23 | +0,00% | 2,29% | 487.400 |
| 29/08/2007 | 33,97 | 34,25 | 33,55 | 34,23 | +0,88% | 2,06% | 619.000 |
| 28/08/2007 | 33,87 | 34,01 | 33,54 | 33,93 | +0,06% | 1,39% | 749.800 |